GASTROINTESTINAL NEOPLASMS
Clinical trials for GASTROINTESTINAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEOPLASMS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Major trial tests Immune-Boosting drug to help beat stomach cancer
Disease control OngoingThis large international study is testing whether adding an immunotherapy drug called durvalumab to standard chemotherapy improves outcomes for people with operable stomach or gastroesophageal cancer. Participants receive the drug combination both before and after surgery to remo…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New knife aims for faster, safer colon polyp removal
Disease control OngoingThis study is comparing two different types of surgical knives used during a minimally invasive procedure to remove precancerous growths (polyps) in the colon. Researchers want to see if a newer 'bipolar' knife is faster and causes fewer side effects like abdominal pain than the …
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
Doctors test if chemo helps rare 'Jelly Belly' cancer
Disease control OngoingThis study aims to find out if standard chemotherapy drugs can slow the growth of a rare abdominal cancer called appendiceal adenocarcinoma. Thirty patients who cannot have complete surgery will either receive chemotherapy first or be observed first, with their tumor growth measu…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New hope to keep cancer treatment on track: drug trial targets Chemotherapy's dangerous side effect
Disease control OngoingThis study is testing if a drug called avatrombopag can help patients with gastrointestinal cancers who develop persistently low platelet counts from their chemotherapy. Low platelets can cause dangerous bleeding and force doctors to delay or reduce chemotherapy doses. About 60 p…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC